12 results
10-K
2019 FY
REPL
Replimune Group Inc
28 Jun 19
Annual report
5:10pm
or regulate the price of medical products and services, particularly for new and innovative products and therapies, which often has resulted … and future healthcare reforms.
Some third-party payors also require pre-approval of coverage for new or innovative devices or therapies before
DRS
tr6wt7630h6tz wmwh
3 May 18
Draft registration statement
12:00am
S-1
772q97385h2iqs jjng
22 Jun 18
IPO registration
5:30pm
S-1/A
vcjwtu6uwat5vzqn
26 Jun 18
IPO registration (amended)
5:24pm
DRS/A
spebe 9i7
11 Jun 18
Draft registration statement (amended)
12:00am
424B4
9v59uac7t
23 Jul 18
Prospectus supplement with pricing info
4:58pm
- Prev
- 1
- Next